1092477-85-4 Usage
Description
(3-chloro-2-pyridinyl)acetic acid hydrochloride, with the molecular formula C6H6ClNO2·HCl, is a chemical compound derived from pyridine and acetic acid. It features a chloro group attached to the 3-carbon position of the pyridine ring, which contributes to its diverse applications in various industries.
Uses
Used in Pharmaceutical Synthesis:
(3-chloro-2-pyridinyl)acetic acid hydrochloride is used as a key intermediate in the synthesis of various pharmaceuticals. Its unique structure allows for the development of new drugs with potential therapeutic applications.
Used in Agrochemical Production:
In the agrochemical industry, (3-chloro-2-pyridinyl)acetic acid hydrochloride serves as a precursor to the development of pesticides. Its incorporation into these products aids in the control and management of pests, thereby enhancing crop protection.
Used as a Herbicide:
(3-chloro-2-pyridinyl)acetic acid hydrochloride exhibits herbicidal properties, making it a valuable component in the development of herbicides. These chemicals are used to control unwanted plant growth, which is crucial for maintaining healthy and productive agricultural fields.
Used in Organic Synthesis Research:
As a research tool, (3-chloro-2-pyridinyl)acetic acid hydrochloride is utilized in studies related to organic synthesis. Its unique structure and reactivity make it an important compound for exploring new synthetic pathways and developing novel chemical entities.
Used in Drug Discovery:
In the field of drug discovery, (3-chloro-2-pyridinyl)acetic acid hydrochloride is employed as a starting material or building block for the design and synthesis of new pharmaceutical compounds. Its versatility and stability contribute to the advancement of drug development efforts.
Used in Agricultural Science:
(3-chloro-2-pyridinyl)acetic acid hydrochloride is also used in agricultural science research, where it helps in understanding the mechanisms of plant growth and development. This knowledge can be applied to improve crop yields and resistance to various stress factors.
The hydrochloride form of (3-chloro-2-pyridinyl)acetic acid enhances its stability and ease of handling in both laboratory and industrial settings, making it a preferred choice for various applications across different industries.
Check Digit Verification of cas no
The CAS Registry Mumber 1092477-85-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,2,4,7 and 7 respectively; the second part has 2 digits, 8 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 1092477-85:
(9*1)+(8*0)+(7*9)+(6*2)+(5*4)+(4*7)+(3*7)+(2*8)+(1*5)=174
174 % 10 = 4
So 1092477-85-4 is a valid CAS Registry Number.
1092477-85-4Relevant articles and documents
N-PHENYL HYDRAZIDES AS MODULATORS OF THE GHRELIN RECEPTOR
-
, (2009/01/24)
The present invention relates to novel compounds of formula (I) or a pharmaceutically acceptable salt or solvate thereof, wherein: each R1 is independently selected from the group consisting of Cl, Br, CH3 and CF3; X is carbon or nitrogen; R1a is H or a straight C1-3 alkyl group; R2a is H or a methyl group R2 is selected from the group consisting of C1-3alkyl, H and -(CH2)n-, wherein n is 3 or 4 and the terminal carbon of the chain is bonded to the carbon atom adjacent to the nitrogen bearing the R2 group, such that a fused 6,5 or 6,6-bicyclic ring is formed. Y is selected from the group consisting of: phenyl which may be unsubstituted or substituted by one or more substituents independently selected from the group consisting of C1-3alkyl, C1-3alkoxy, halogen, C1-3alkyl substituted by 1 to 7 fluoro atoms and C1-3alkoxy substituted by 1 to 7 fluoro atoms; pyridyl which may be unsubstituted or substituted by one or more substituents independently selected from the group consisting of C1-3alkyl, OCH3, CF3, CN, and halogen; naphthyl which may be unsubstituted or substituted by one or more substituents independently selected from the group consisting of F and OCH3; pyrimidinyl; imidazo[1,2-a]pyridine-6-yl; benzothiophen-2-yl; benzothiophen-5-yl; benzofuran-2-yl; dibenzo[b,d]furan-3-yl; dibenzo[b,d]thiophen-2-yl; dibenzo[b,d]thiophen-4-yl; 1,3- benzodioxol-5-yl; 2,3-dihydro-1,4-benzodioxin-5-yl; 2,3-dihydro-1,4-benzodioxin-6-yl; 2,3- dihydro-1-benzofuran-4-yl; 2,2-difluoro-1,3-benzodiox-4-yl; pyridazinyl; imidazolyl; oxazolyl; pyrazolyl; thiazolyl; and triazolyl; with the proviso that when Y is 2,3-dihydro-1,4-benzodioxin-6-yl, R1 is not Cl; processes for their preparation, intermediates useble in these processes, pharmaceutical compositions containing them and their use in therapy, for example as modulators of of the growth hormone secretagogue receptor (also referred to as the ghrelin receptor or GHSR1a receptor) and/or for the treatment and/or prophylaxis of a disorder mediated by the ghrelin receptor.
